Evidence map›Paper›PMID 40507972›Full record

ArticleInternational journal of molecular sciences2025

Alkyltriphenylphosphonium-Functionalized Hyperbranched Polyethyleneimine Nanoparticles for Safe and Efficient Bacterial Eradication: A Structure-Property Relationship Study.

Katerina N Panagiotaki, Kyriaki-Marina Lyra, Aggeliki Papavasiliou, Dimitris Tsiourvas, Zili Sideratou

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katerina N PanagiotakiInstitute of Nanoscience and Nanotechnology, National Centre of Scientific Research ''Demokritos", 15310 Aghia Paraskevi, Attiki, Greece.
Kyriaki-Marina LyraInstitute of Nanoscience and Nanotechnology, National Centre of Scientific Research ''Demokritos", 15310 Aghia Paraskevi, Attiki, Greece.
Aggeliki PapavasiliouInstitute of Nanoscience and Nanotechnology, National Centre of Scientific Research ''Demokritos", 15310 Aghia Paraskevi, Attiki, Greece.
Dimitris TsiourvasInstitute of Nanoscience and Nanotechnology, National Centre of Scientific Research ''Demokritos", 15310 Aghia Paraskevi, Attiki, Greece.
Zili SideratouInstitute of Nanoscience and Nanotechnology, National Centre of Scientific Research ''Demokritos", 15310 Aghia Paraskevi, Attiki, Greece.ORCID 0000-0002-9314-2520

Funding

NCSR Demokritos internal project EE11968State Scholarships Foundation MIS 5000432
6 · The paper itself

Abstract

Polymeric antibacterial agents are attracting attention due to their increased bactericidal efficiency and low probability of causing drug resistance. Their activity, usually attributed to electrostatic interactions and subsequent disruption of cell membranes, is attributed to the number and chemical structure of their functional groups. In this study, hyperbranched polyethyleneimines (PEIs) of two different molecular weights were functionalized with amphiphilic alkyltriphenylphosphonium groups, which are known to induce membrane penetration, especially in cells with high membrane potential. The obtained nanoparticles were chemically and physicochemically characterized, and their inhibition potential against Gram (-)

Indexed as

Anti-Bacterial AgentsNanoparticlesOrganophosphorus CompoundsPolyethyleneimineEscherichia coliHumansMicrobial Sensitivity TestsStaphylococcus aureusStructure-Activity RelationshipAnti-Bacterial AgentsOrganophosphorus CompoundsPolyethyleneiminebactericideshyperbranched polymersnanoparticlestriphenylphosphonium cation

Identifiers

PMID40507972
PMCPMC12155293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.